Oral thymosin alpha-1 showed immunomodulatory effects in mice, enhancing T-cell and NK cell function after gastrointestinal administration — proving oral peptide immune therapy is feasible.
Key findingOral thymosin alpha-1 enhanced T-cell function, NK cell activity, and cytokine production in mice, demonstrating that the peptide retains immunomodula
What the researchers found
Oral thymosin alpha-1 enhanced T-cell function, NK cell activity, and cytokine production in mice, demonstrating that the peptide retains immunomodulatory activity after oral administration — a practical advance for non-injectable immune therapy.
Why it matters
Relevant for thymosin-alpha-1, immune-function, bioavailability, oral-peptides.
How the study worked
animal-study study on thymosin-alpha-1, immune-function.
What this study cannot tell us
See abstract.
How to read the evidence
preliminary evidence.
When this study was published
Published in 2005.
The bigger picture
Advances peptide research with clinical implications.
Questions still open
- Further research needed.
- Clinical translation to evaluate.
Common questions
What was studied?
What was found?
Read the original research
Immunomodulatory function of orally administered thymosin alpha1.
Journal of Zhejiang University. Science. B, 6(9), 873-6
Citation
Chen, Xiang-Ming; Jiang, Han-Liang; Zhou, Lin-Fu; Pan, Xiao-Ping; Hu, Zhong-Rong; Liu, Rong-Hua; Chen, Xiao-Ming; Chen, Zhi. (2005). Immunomodulatory function of orally administered thymosin alpha1.. Journal of Zhejiang University. Science. B, 6(9), 873-6.